Radioactive microshperes for the treatment of CNS tumours

A central nervous system and radionuclide technology, applied in the direction of radioactive physical shape, antineoplastic drugs, preparations for in vivo experiments, etc., can solve problems such as poor results

Pending Publication Date: 2021-12-28
BIOCOMPATIBLES UK LTD +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The current standard of care is external beam radiation therapy (EBRT

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Radioactive microshperes for the treatment of CNS tumours
  • Radioactive microshperes for the treatment of CNS tumours
  • Radioactive microshperes for the treatment of CNS tumours

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0075] The present disclosure will now be described by reference to the following non-limiting illustrative examples. Based on these embodiments, other embodiments will occur to those skilled in the art.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
The average diameteraaaaaaaaaa
Diameteraaaaaaaaaa
Diameteraaaaaaaaaa
Login to view more

Abstract

A method of treating CNS tumors such as gliomas is provided comprising delivering a beta-emitting radionuclide containing composition to the tumor via the cerebral vasculature.

Description

[0001] related application [0002] This application claims the benefit of U.S. Provisional Patent Application Serial No. 62 / 816,833, filed March 11, 2019, and U.S. Provisional Patent Application Serial No. 62 / 823,954, filed March 26, 2019, the entire disclosures of which are incorporated in Incorporated herein by reference. technical field [0003] The present disclosure relates to the treatment of central nervous system cancers using beta-radiation emitting radionuclides (β-emitting radionuclides), especially when delivered via cerebral blood vessels. In particular, the present disclosure relates to the use of injectable compositions comprising substances comprising radionuclides in the treatment of central nervous system cancers, more particularly high grade axial brain tumors, including hypervascularized tumors such as gliomas. Background technique [0004] Central nervous system (CNS) cancers are very difficult to treat, with high-grade gliomas being difficult to remo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K51/12
CPCA61P35/00A61K2121/00A61K51/1251A61K9/0019A61K51/1255
Inventor 亚历山大·帕赛克克利福德·韦斯马修·R·德雷尔
Owner BIOCOMPATIBLES UK LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products